Treatment of Bacterial Conjunctivitis
Topical antibiotics are recommended for bacterial conjunctivitis as they reduce symptom duration and improve clinical outcomes, even in mild cases. 1
Treatment Based on Severity
Mild Bacterial Conjunctivitis
- A 5-7 day course of broad-spectrum topical antibiotic is recommended as it accelerates clinical and microbiological remission in days 2-5 of treatment 2, 1
- Treatment reduces transmissibility and allows earlier return to school/work 2, 1
- While mild bacterial conjunctivitis may resolve spontaneously, antibiotics shorten the duration of symptoms 2
- The choice of antibiotic is usually empiric, with no evidence suggesting superiority of any particular antibiotic 2
Moderate to Severe Bacterial Conjunctivitis
- Characterized by copious purulent discharge, pain, and marked inflammation 2, 3
- Obtain conjunctival cultures and Gram staining before initiating treatment, especially if gonococcal infection is suspected 2, 1
- The choice of antibiotic should be guided by laboratory test results 2
Recommended Antibiotics
- Fluoroquinolones (e.g., moxifloxacin, gatifloxacin) are effective against common pathogens including Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae 4, 5
- Aminoglycosides like tobramycin are also effective options 1, 6
- For areas with limited antibiotic access, povidone-iodine 1.25% ophthalmic solution may be as effective as topical antibiotics 2, 1
Special Considerations
Gonococcal Conjunctivitis
- Requires systemic antibiotic therapy rather than topical treatment alone 2, 1
- Saline lavage may promote comfort and faster resolution of inflammation 2
- Patients should be seen daily until resolution 2
- Sexual contacts should be informed and referred appropriately 2
Chlamydial Conjunctivitis
- Requires systemic antibiotic therapy, especially in infants who may have infection at other sites 2, 1
- No evidence supports additional topical therapy beyond systemic treatment 1
- Re-evaluation following treatment is necessary due to potential treatment failure (up to 19%) 2
Methicillin-Resistant Staphylococcus aureus (MRSA)
- MRSA has been isolated with increasing frequency from patients with bacterial conjunctivitis 2
- MRSA organisms are resistant to many commercially available topical antibiotics 2
- Microbiology laboratory testing may guide therapy, which may include compounded topical antibiotics such as vancomycin 2, 1
Follow-up Recommendations
- Patients should be advised to return for follow-up if no improvement is seen after 3-4 days of treatment 2, 3
- Follow-up should include interval history, visual acuity measurement, and slit-lamp biomicroscopy 2, 3
Important Considerations and Pitfalls
- Avoid using topical corticosteroids unless under close supervision, as they may worsen infection 3
- Bacterial resistance is a growing concern, particularly with MRSA infections 1, 7
- For children with gonococcal or chlamydial infections, consider the possibility of sexual abuse 2, 1
- Poor adherence to frequent administration regimens can contribute to treatment failure 7
- Advise patients about hygiene measures to prevent spread, such as frequent hand washing and avoiding sharing of personal items 3, 6